Canale-Theakston joins ranks of exceptional entrepreneurs in San Diego

SAN DIEGO – MAY 15, 2019 – EY today announced that Carin Canale-Theakston, founder and chief executive officer of Canale Communications, is a finalist for the Entrepreneur Of The Year® 2019 Award in the San Diego region. Widely considered one of the most prestigious business awards programs in the U.S., the program recognizes entrepreneurs and leaders of high-growth companies who are excelling in areas such as innovation, financial performance and personal commitment to their businesses and communities, while also transforming our world.

Canale-Theakston was selected as a finalist by a panel of independent judges. Award winners will be announced at a special black-tie gala event on June 6 at the Fairmont Grand Del Mar.

“While I am incredibly honored to be selected as an Entrepreneur of the Year finalist, more than anything, I am humbled to be joining a list of individuals who I truly respect and admire,” said Carin Canale-Theakston, the agency’s founder and chief executive officer. “In being recognized as an integral part of the San Diego business community, this award helps to highlight the strategic counsel that Canale Communications has successfully delivered to a wide range of life science companies all across the map.”

Now in its 33rd year, the program recognizes business leaders in more than 145 cities and more than 60 countries throughout the world.

To learn more about the San Diego program, please visit www.ey.com/us/eoy/sandiego. Join the conversation on social media by following us @EY_EOYUS and using #EOYSD

Regional award winners are eligible for consideration for the Entrepreneur Of The Year National Competition. Award winners in several national categories, as well as the Entrepreneur Of The Year National Overall Award winner, will be announced at the Entrepreneur Of The Year National Awards gala in Palm Springs, California, on November 16, 2019. The awards are the culminating event of the Strategic Growth Forum®, the nation’s most prestigious gathering of high-growth, market-leading companies.

Sponsors
Founded and produced by Ernst & Young LLP, the Entrepreneur Of The Year Awards are nationally sponsored by SAP America and the Ewing Marion Kauffman Foundation.
In San Diego, local sponsors include gold sponsors: Cooley and Lockton, LLC.

About Canale Communications
Canale Communications is a privately-held, strategic communications and creative firm exclusively serving the life science and healthcare industries, with a focus on emerging companies. The company has worked with more than 300 biotech, health tech and pharmaceutical companies at virtually every stage of development. The firm specializes in corporate communications, public relations, investor communications, website development, creative services, content creation and distribution, and social media. Canale Communications primarily serves clients headquartered in the biotech hubs of Southern California and the San Francisco Bay Area, and also extends to other life science markets that are home to some of the hottest new biotech and digital health companies. Visit CanaleComm.com to learn more.

About Entrepreneur Of The Year®
Entrepreneur Of The Year®, founded by EY, is the world’s most prestigious business awards program for entrepreneurs. The program makes a difference through the way it encourages entrepreneurial activity among those with potential and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global awards program of its kind, Entrepreneur Of The Year celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 145 cities and more than 60 countries. ey.com/eoy

About EY’s Growth Markets Network
EY’s worldwide Growth Markets Network is dedicated to serving the changing needs of high-growth companies. For more than 30 years, we’ve helped many of the world’s most dynamic and ambitious companies grow into market leaders. Whether working with international mid-cap companies or early stage, venture-backed businesses, our professionals draw upon their extensive experience, insight and global resources to help your business succeed. For more information, please visit us at ey.com/gm or follow news on Twitter @EY_Growth.

About EY
EY is a global leader in assurance, tax, transaction and advisory services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.

EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. Information about how EY collects and uses personal data and a description of the rights individuals have under data protection legislation is available via ey.com/privacy. For more information about our organization, please visit ey.com.

SAN DIEGO, Sept. 21, 2018 — Canale Communications Inc., an award-winning life science communications firm, has been named one of the Best Places to Work in San Diego for the third consecutive year. Presented and judged by the San Diego Business Journal and Best Companies Group, Canale Communications was awarded in the “Small Companies” category.

“Being named a Best Place to Work is one of the most meaningful and greatest honors, especially as the company continues to expand,” said Carin Canale-Theakston, the agency’s founder and chief executive officer. “Ultimately, the effective communications strategies and creative services we deliver to clients are dependent upon having engaged employees who feel connected not only to one another, but also to the work they produce. This award highlights the spirit of collaboration and fun that unifies our team.”

Consisting of a two-part survey process, contributed by both the employer and the employees, the Best Places to Work awards program is designed to identify, recognize and honor the best employers in San Diego—benefitting the county’s economy, workforce and businesses. The list is divided into four groups: small companies (15-49 employees), medium-sized companies (50-249 employees), large companies (250-1,999 employees) and mega-sized companies (2,000 or more employees).

Since the firm was founded in 2010, Canale Communications has become known for its positive culture and enthusiastic involvement in the local life science industry. Weekly bootcamp-style workouts, catered lunches and lavish anniversary parties are a few of the many perks employees receive, on top of competitive compensation and bonuses. The company has grown tremendously in size and experience over the past eight years, to more than two-dozen employees and over 300 life science companies served, making it the largest independent life science communications agency in California.

For more information on the Best Places to Work in San Diego program, visit www.BestPlacestoWorkSD.com.

 

About Canale Communications

Canale Communications is a privately-held, strategic communications and creative firm exclusively serving the life science and healthcare industries, with a focus on emerging companies. The company has worked with more than 300 biotech, health tech and pharmaceutical companies at virtually every stage of development. The firm specializes in corporate communications, public relations, investor communications, website development, creative services, content creation and distribution, and social media. Canale Communications primarily serves clients headquartered in the biotech hubs of Southern California and the San Francisco Bay Area, and also extends to other life science markets that are home to some of the hottest new biotech and digital health companies. Visit CanaleComm.com to learn more.

San Diego-based Canale Communications recently made Inc. magazine’s annual Inc. 5000 list of the fastest-growing privately-owned businesses in the U.S. Here, the life science agency’s founder and CEO Carin Canale-Theakston talks to us about what being on the Inc. 5000 list means to her — and how she wisely manages her company’s growth.

The Inc. 5000 list recognizes fast-growing private businesses that are creating the most value and jobs. As an Inc. 5000 company, how has Canale Communications managed its progressive and substantial growth?

Canale-Theakston: As a business owner, I’m proud that we have achieved a level of growth deemed exceptional by the Inc. editorial team. By the numbers, growth is important and helps position us as a leader and advocate within the life sciences community we serve. But when I think about growth, I think about smart growth. We don’t want to get too big too fast, or feel pressure to accept new opportunities that don’t fit our ethos as a company. Smart growth, to me, means hiring great people with varied skill sets and experience, and retaining a really strong leadership team to support and lead our growth. These are both things I believe we do well. Our staff brings together an incredible variety of talents that span public relations, investor relations, website development and more. And most of our senior leadership team has been with us from day one.

That’s great insight into your philosophy on growth. Many of the Inc. 5000 companies sell a product. But as a communications consultancy and knowledge service provider, Canale Communications provides something quite different. How do you view growth in comparison to your Inc. 5000 peers?

Canale-Theakston: Great question. As a life science communications firm, we do sell a service and not a product — and because of that, our reputation is everything. At the end of the day, the work we do on behalf of our partners, and the work they do with us as their communications backbone, becomes our brand. It’s important that we say yes to work that aligns with our values, is exciting to our team and is important to society in some way. All money is not created equal. We do say no to potential business that could represent significant revenue if that business could jeopardize our reputation. And we say yes to potential business that might only be a fraction of our revenue goal because we see it as a differentiating opportunity — maybe it’s a mobile health startup with an all-star team or an early-stage drug company an incredible technology. As a privately-held business, we have the luxury and the challenge of being selective about who we work with and why.

Thank you. As you prepare to celebrate your Inc. 5000 recognition with your team, are there any additional thoughts you’d like to share on why growth matters?

Canale-Theakston: I would just reiterate that growth for growth’s sake is a fool’s errand, and a sentiment with which the life science entrepreneurs we serve — many of whom are working tirelessly to save lives and help people — would likely agree. To me, smart growth means choosing wisely, working with the best people and remaining focused on what we love: communicating new scientific and technology advancements that improve peoples’ lives.

We’re kicking off a year that’s predicted to be a big one for biotech IPOs. And based on the resurgence of IPO filings by life science companies at the tail end of 2017, those predictions look like they’re already translating into reality.

If investor appetite continues, we expect more and more emerging biotech and pharma companies to be looking to the public markets to fund the development of their pipeline.

Yet, for even the most seasoned executive teams, the path leading to an IPO can be filled with stresses and surprises — so it’s beneficial to be surrounded by a professional team that you know and trust, said Jason Spark, managing director of Canale Communications and a moderator at the Marsh IPO Bootcamp, held at JLABS in San Diego.

Here are some more tokens of advice from the recent IPO Bootcamp, sponsored by Marsh & McLennan Agency.

1. Confidential S-1 filings won’t be stealth forever. 

Any company planning to go public must first submit a Form S-1 with the U.S. Securities and Exchange Commission. The S-1 is a content-rich document in which the company describes its business model, technology, competition, planned use of proceeds, reasoning behind the proposed stock offering price and other details.

As of July 2017, the SEC began to allow all companies to confidentially submit registration documents, offering privacy for companies who are still testing the waters. Smaller, emerging growth companies have benefited from confidential filing under the JOBS Act since 2012.

When putting together the S-1, remember that the confidential filing will eventually become public — including any changes made to the S-1, such as changes requested by the SEC — if the company chooses to proceed with an IPO. A confidential S-1 must be flipped public 15 days before the road show can begin. Thus, use caution in the “confidential” S-1 when discussing development timelines and other company details that may fluctuate before the IPO. You don’t want investors find surprises or perceived squishiness in strategy that will cost you their confidence.

2. Establish your company story and set milestones as soon as possible — then, stick with it.

A clear, crisp story goes a long way in generating investor support. Most emerging biotech companies don’t have a revenue story to lean on, at least in the beginning. Companies instead rely heavily on sharing how they’re solving a big problem, the validation behind their product or technology, and the credibility of their management team to deliver on a plan.

This is one reason that most new client relationships at Canale Communications start with a positioning workshop — a practice that’s useful for all companies, but particularly for a pre-IPO biotechs establishing their corporate story and preparing to draft their S-1. In these interactive sessions, the executive team and all major stakeholders meet for an in-depth, all-inclusive exercise that hones in on the company’s strengths, weaknesses, differentiators, competitive landscape and value drivers. The result is company messaging that will be compelling and memorable.

Along with this, media training and speaker training are both extremely helpful. The CEO and executive team must be prepared for prime time, as they will become the face of the company in the months leading up to the IPO and in the years afterward.

IPO hopefuls also should identify and communicate milestones they plan to hit in coming months and years. When will clinical trials enroll? When do you expect data readouts? Give yourself wiggle room when determining dates; missing a deadline will not reflect well on you, while meeting them will show investors you’ve been following a pattern of hitting goals as planned.

3. Start acting like a public company now.

You can never control when the market will be favorable for an IPO. But can control whether you’re prepared to launch when the time is right. If an IPO is a possibility in the future, start acting like a public company as soon as possible.

This is important because once you officially begin the IPO process, you will be subject to a designated quiet period during which the SEC requires that you maintain your “normal” business practices. So begin to “normalize” practices such as issuing press releases, announcing publications, and publicizing or participating in conference presentations.

Getting to an IPO may be one of the most grueling journeys for a biotech executive, but it can also be one of the most rewarding. For more tips on pre-IPO communications and strategy, stay tuned to the CanaleComm blog or contact us to talk.  

This article includes select insights from the panel “IPO Pre-Game: Getting Ready for IPO,” which kicked off the Marsh IPO Bootcamp, hosted by Marsh & McLennan Agency. The panel  featured Sean Clayton, Cooley LLP; Bruce Rucks, Deloitte; Mark Doscher, Marsh & McLennan Agency, and was moderated by Jason Spark, Canale Communications.  

 

If you’re in need of a few perfect holiday gifts for friends or family who feel as passionately about science as you do, the folks at CanaleComm have some good ideas for you. These ideas are so good, in fact, that they’ve been published in BioWorld‘s 2017 holiday gift guide.

The magazine’s annual list kicks off with a smart suggestion from our very own Heidi Chokeir, Ph.D., a managing director at CanaleComm who sometimes forgets that she’s not a scientist anymore. Heidi recommends the Foldscope Individual Deluxe Kit, which she calls “an amazing gift for the budding scientists in people’s lives.” The kits, which sell for $39.99, “allow curious explorers to perform microscopy experiments anywhere at any time,” according to the website. For a fun add-on, buy the Foldscope T-shirt, featuring an adorable tardigrade on the back. 

The BioWorld gift guide also included a handful of bright ideas from Sumitra Gupta, account associate at CanaleComm. Among them: the Climate Change Coffee Mug from The Unemployed Philosophers Guild. When you pour hot liquid into the mug, sold for $13.99, you’ll see just what will happen when the polar ice caps melt. “Before your very eyes, coastlines shrink and ocean levels rise, Florida dissolves and Central America all but vanishes,” according to the website.  

Sumitra also recommends the Vaccines Cause Adults T-shirt sold on CureGear. While you can buy t-shirts with this catchy slogan on many sites, CureGear donates $5 from every $25 t-shirt purchase to the Bill & Melinda Gates Foundation, which is working to increase vaccine coverage around the world.

Want more ideas? Check out these other great gift lists that focus on science:

Happy shopping…and more importantly, happy holidays from the whole team at CanaleComm!